• Home
  • Top Stories
  • Markets
  • Market Data
  • Companies
  • Opinion
  • Economy & Policy
  • Finance
  • Politics
  • Technology
  • Personal Finance
  • Current Affairs
  • International
  • Management
  • Weekend
  • General News
  • Latest News
  • Today's Paper
  • Videos
  • Covid-19
  • Portfolio
  • Login

Zydus Cadila
Zydus Cadila says 'positive results' from phase 2 studies of Covid-19 drug
Serum, Bharat Biotech vaccines get restricted use approval from DCGI
Zydus gets DCGI nod for conducting phase-3 clinical trials of ZyCoV-D
What sets Zydus Cadila apart among indigenous players in Covid vaccine race
Zydus Cadila receives drug regulator's nod for NAFLD medicine in India

Zydus gets DCGI approval for phase-3 clinical trials of Covid-19 therapy
Zydus Cadila gets nod to start phase 3 trials of Covid vaccine on patients
PM visit will motivate us to 'bridge unmet healthcare needs': Zydus Cadila
Modi reviews vaccine development at Zydus Cadila facility near Ahmedabad
Pfizer vaccine's -70 degree storage norm tough for most nations: V K Paul

Zydus completes phase 2 clinical trial in Covid patients with bio-therapy
Zydus Cadila files investigational new drug application for coronavirus
Zydus Cadila Q2 net up four-fold on surge in US sales, strong show at home
Zydus Cadila gets USFDA nod for overactive bladder treatment drug
Zydus Cadila gets USFDA nod to market Verapamil Hydrochloride Injection
Govt exploring options on financing Covid vaccine development: Health secy
Indian samples of global Covid-19 vaccines need to be larger: Experts
Zydus Cadila gets USFDA nod for multiple sclerosis treatment drug
Zydus Cadila gets tentative USFDA approval to market anti-cancer drug
Zydus Cadila gets USFDA nod to market mineral supplement tablets
Next 
⇧ Back to Top
  • Top Stories
  • Markets
  • Market Data
  • Companies
  • Opinion
  • Economy & Policy
  • Finance
  • Politics
  • Technology
  • Personal Finance
  • Current Affairs
  • International
  • Budget 2020
  • Insurance Round Table 2020
View Full Site >>
Copyrights © 2021 Business Standard Private Ltd. All rights reserved